LUTON, BEDFORDSHIRE, UK, Sept 02, 2022 (GLOBE NEWSWIRE) — Exactitude Consultancy, the market research and consulting arm of Ameliorate Digital Consultancy Private Limited, has released the final version of its in-depth research report on the capnography equipment market. was completed and published. .
The global capnography equipment market is expected to grow at a CAGR of over 8.2% from 2019 to 2028. It is expected to grow from just over US$550 million in 2021 to over US$930.45 million by 2028.
Increased Use of Capnographic Devices During Surgical Procedures and Postoperative Monitoring, Global Recommendations for the Use of Capnographic Devices During Patient Monitoring for Anesthesia (to Improve Patient Safety), Factors such as reimbursement of capnography equipment for post-operative monitoring across developed countries, and the number of complex and critical surgical procedures are increasing.
Because of the favorable clinical results, capnography devices have emerged as the preferred option for monitoring airway malignancies. There is growing awareness of the availability of minimally invasive procedures with few side effects among people suffering from central airway obstruction, chronic obstructive pulmonary disease (COPD), lung cancer, and asthma, with effective, non-invasive monitoring methods. There is increasing acceptance of capnography.
(Please be careful This report sample has been modified to include a COVID-19 impact study prior to delivery. )
Get a sample containing the latest trends and future advancements: (Make your corporate email identity a priority): https://exacttitudeconsultancy.com/reports/1470/capnography-equipment-market/#request-a-sample
Regional Opportunities – In 2021, North America accounted for the largest revenue share of the global market with over 29%. By region, North America held the largest market share in the global capnography devices market, followed by Europe and Asia Pacific. This growth can be attributed to the region’s high patient population, strong presence of device manufacturers and the rising prevalence of respiratory diseases as a result of unhealthy lifestyles. , high stress levels were the main factor leading to significant adoption. Sales of capnography equipment in North America.
Masimo Announces FDA Approval of Radius PCG™ for Root® Patient Monitoring and Connectivity Platform
Masimo – Today announced that the Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance. The Radius PCG connects with the Root® patient monitoring and connectivity platform to provide seamless, tetherless mainstream capnography for patients of all ages. The Radius PCG joins the growing family of tetherless Masimo technologies, including Radius PPG™, which provides Masimo SET® Measure-through Motion and Low Perfusion pulse oximetry, and Radius Tº™, which provides continuous temperature measurement. The Radius PCG accurately measures end-tidal carbon dioxide (EtCO2) and respiratory rate without the need for periodic calibration and displays a continuous waveform of EtCO2 within 15 seconds. All in a small, portable package that fits in the palm of your hand.
Latest Press Release – https://exacttitudeconsultancy.com/post/capnography-equipment-market-growth/
Capnography Equipment Market Scope and Segmentation
|Target segment:||Product segment, technology segment, application segment, end-user segment|
|Region and country coverage||North America: Including US, Canada and Mexico
Asia Pacific: Including China, Japan, Korea, India, Australia, ASEAN and rest of APAC
Europe: Including UK, Germany, France, Italy, Spain, Russia and rest of Europe
South America: Including Brazil, Argentina and the rest of South America
Middle East and Africa: Includes Turkey, UAE, Saudi Arabia, South Africa and other MEAs
|Report coverage:||Market Growth Drivers, Challenges and Pitfalls, Opportunities, Trends, Analysis of Key Players, Regional Analysis|
|Target market players||Nihon Kohden (Japan), Philips (Netherlands), Medtronic (Ireland), Smith Group (UK), Masimo Corporation (US), Drägerwerk AG & Co. KGaA (Germany)|
|Largest regional market||North America (39%)|
|market growth||Capnography devices are suitable for respiratory monitoring because they are cost-effective and non-invasive. The industry is benefiting from an aging population and changing lifestyles. Advances in technology have fueled the development of portable and effective automated capnography devices. In addition, strategic activities by major players are driving the expansion of the market. For example, Masimo announced in April 2021 that his portable Capnograph, the Radius PCG, received FDA 510(k) clearance. A wireless Bluetooth connection is included in the gadget. Capsule Technologies received FDA approval for its revolutionary connected capnography surveillance technology in September 2020. This has expanded the company’s product portfolio.|
View detailed research insights on TOC:
Capnography Device Market Demand
Capnography devices are expected to see increased demand in the coming years as they can improve the outcome of the aforementioned procedures. Several government authorities and research groups have issued guidelines highlighting the need for this device in medical settings.
However, the lack of experienced professionals with technical knowledge of capnography tools may hinder market expansion. Capnography equipment is sophisticated and requires a qualified operator to operate. Use of these devices may be limited due to lack of qualified personnel, especially in developing countries. Additionally, the exorbitant costs associated with various capnography equipment may hamper the growth of the industry. In addition, the US Food and Drug Administration (FDA) closely oversees the development of these devices and authorizes their commercialization according to their performance.
Key Market Segment: Capnography Equipment Market
Product Segments, 2019-2028 (USD million)
- handheld capnometer
- Conventional capnometer
- Multiparameter capnometer
- standalone capnometer
Technology Segment, 2019-2028 (USD million)
- Sidestream capnography
- mainstream capnography
- microstream capnography
Application Segment, 2019-2028, (USD Million)
- heart care
- trauma and emergency care
- respiratory monitoring
- Other applications
Detailed TOC of Global Capnography Equipment Market Research Report 2022
|3||Regulatory and patent analysis|
|Four||Key factor analysis|
|Five||Porter’s Five Forces Analysis|
|6||Impact Analysis of COVID-19 on Capnography Equipment Market|
|7||Market composition of capnography equipment|
|8||Global Company Share Analysis – Key Companies|
|9||Capnography Equipment Market Company and Product Profiles|
|11||Report Coverage – Market Trends, Drivers, Constraints, Competitive Analysis, Player Profiling, Regulatory Analysis|
Check discounts on this study: https://exacttitudeconsultancy.com/reports/1470/capnography-equipment-market/#inquire-for-discount
See more research topics in the healthcare field:
Cancer diagnostic market
The market size of cancer diagnostics was valued at USD 16.87 billion in 2020 and is projected to reach USD 44.22 billion by 2029, growing at a CAGR of 11.3% from 2022 to 2029.
Current cancer diagnosis and treatment methods have serious deficiencies. Since the last decade, new nanoplatforms have emerged that simultaneously provide cancer diagnostic and therapeutic capabilities as a result of increasing knowledge and technological advances in cancer biology, materials science, and especially nanomedicine.
Cancer biomarker market
The market size of cancer biomarkers was valued at USD 11.38 billion in 2020 and is projected to reach USD 48.58 billion by 2029, growing at a CAGR of 17.5% from 2022 to 2029.
Cancer biomarkers are substances or activities that can be used to detect the presence of cancer in the body. A biomarker is a chemical produced by a specific body response to the presence of a tumor or cancer. Genetic, epigenetic, proteomics, glycomics, and imaging biomarkers can be used in cancer diagnosis, prognosis, and epidemiology.